Kissei Pharmaceutical Co., Ltd. (KSPHF) Comparison with companies in other sectors?

Kissei Pharmaceutical Co., Ltd. has a share price of 41.44M. You can analyze Kissei Pharmaceutical Co., Ltd. (KSPHF) competitors across different market sectors through stock heatmaps.

What are KSPHF's NET and operating margins?

Kissei Pharmaceutical Co., Ltd. (KSPHF) operating margin is around 0.07, and net profit margin is approximately 0.14 as of the latest reports.

In what way does KSPHF's earnings per share (EPS) trend reflect its financial momentum?

Kissei Pharmaceutical Co., Ltd. (KSPHF) EPS is 1.87 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Kissei Pharmaceutical Co., Ltd. is 14.51, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Kissei Pharmaceutical Co., Ltd.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Kissei Pharmaceutical Co., Ltd. like P/E which is 14.33, P/B which is 0.82, and PEG which is 0.02. Compare them with sector averages to evaluate if the stock is priced fairly.

Kissei Pharmaceutical Co., Ltd.

KSPHF•PNK

Healthcare

Drug Manufacturers - Specialty & Generic

$27.13

$0.00(0.00%)

Fundamental Analysis of Kissei Pharmaceutical Co., Ltd. (KSPHF)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$1.87

P/E Ratio

14.51

ROE

0.06%

Net Margin

0.14%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$1.12B

Shares OutstandingTotal number of shares issued

$41.44M

Book Value/ShareNet worth per share

$4908.89

Revenue/ShareAnnual revenue per share

$2063.54

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$1.87

Net MarginNet income as percentage of revenue

13.54%

Operating MarginOperating income as percentage of revenue

6.54%

ROEReturn on shareholders' equity

5.57%

ROAReturn on total assets

4.90%

ROCEReturn on capital employed

2.54%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

$1136.64

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$46.89

Dividend YieldAnnual dividend as percentage of stock price

1.17%

Financial Ratios Analysis data is not available for KSPHFFinancial Ratios Analysis details for KSPHF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for KSPHFSector Benchmarking details for KSPHF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Kissei Pharmaceutical Co., Ltd. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Kissei Pharmaceutical Co., Ltd.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Kissei Pharmaceutical Co., Ltd.'s unique business strengths and challenges.

Key Financial Metrics for Kissei Pharmaceutical Co., Ltd.

For Kissei Pharmaceutical Co., Ltd., essential financial indicators include EPS 1.87, PE 14.51, and ROE 0.06. These key ratios reveal insights into Kissei Pharmaceutical Co., Ltd.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Kissei Pharmaceutical Co., Ltd. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Kissei Pharmaceutical Co., Ltd.

Metrics like Net Margin 13.54% and ROA 4.90% shed light on how well Kissei Pharmaceutical Co., Ltd. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Kissei Pharmaceutical Co., Ltd. can sustain its operations and continue growing in the future.

Valuation and Market Position of Kissei Pharmaceutical Co., Ltd.

Using ratios such as P/B Ratio 0.82 and PEG Ratio 0.02, investors can assess whether Kissei Pharmaceutical Co., Ltd. is appropriately valued based on its financials and growth potential. These figures, combined with Kissei Pharmaceutical Co., Ltd.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Kissei Pharmaceutical Co., Ltd.

Financial health indicators, such as Debt/Equity Ratio 0.006 and Cash Flow -, provide a snapshot of Kissei Pharmaceutical Co., Ltd.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Kissei Pharmaceutical Co., Ltd., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Kissei Pharmaceutical Co., Ltd.

Investing in Kissei Pharmaceutical Co., Ltd. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Kissei Pharmaceutical Co., Ltd. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;